Strata Critical Medical Q3 2026 net loss from continuing operations narrows 21% year-over-year to $7.62 million; Q3 2026 revenue rises 50% year-over-year to $74.08 million
Bitget2026/11/03 12:13- Strata Critical Medical’s Q3 2026 net loss from continuing operations narrowed 21% year-over-year to $7.62 million.
- Revenue climbed 50% year-over-year to $74.08 million, driven by Clinical acquisitions, partially offset by Logistics.
- A new $20 million share repurchase authorization will be deployed alongside the acquisition strategy.
- Revenue guidance for 2026 remained at $285 million–$295 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Japanese and South Korean stock markets open
Marvell Technology (MRVL.US) $115 billion "merger of the century" faces lukewarm reception! Stock has dropped over 40%, experts estimate only a 50% chance of completion
Marvell plans to acquire Lamington for 115 billions USD to strengthen its position in AI, but the probability of completion is only 50%. The two stocks have dropped by nearly 40% and about 35% respectively, with Chinese regulatory approval being the biggest uncertainty.
Amid opposition to data centers, Musk doubles down: SpaceX (SPCX.US) plans to build a $24 billion computing center and gas power plant in Texas.
According to a public hearing notice published on the Starbase website, SpaceX plans to build, own, and operate a gas-fired power plant and a supercomputing facility at its company town in Starbase, Texas.
Crypto prices
More
